Table: Zeria Pharm - 6-MTH group results
Nov 4 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2021 Sep 30, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 28.61 25.52 60.00
(+12.1 pct) (+13.7 pct)
Operating 2.67 1.60 5.30
(+67.2 pct) (+52.5 pct)
Recurring 3.12 1.31 5.20
(+138.4 pct) (+62.1 pct)
Net 2.12 1.39 3.70
(+52.4 pct) (+17.7 pct)
EPS 46.65 yen 30.05 yen 81.80 yen
Ann Div 34.00 yen 34.00 yen
-Q2 div 17.00 yen 17.00 yen
-Q4 div 17.00 yen 17.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T